BioSpace News Archive

Gain Therapeutics, Inc. announced its financial results for the first quarter ended March 31, 2022, and highlighted recent corporate accomplishments.

Ginkgo Bioworks Holdings, Inc., the leading horizontal platform for cell programming, announced its results for the first quarter ended March 31, 2022.

Ardelyx, Inc. announced that on May 9, 2022, the compensation committee of the company’s board of directors granted three new non-executive employees options to purchase an aggregate of 26,953 shares of the company’s common stock, and granted an aggregate of 29,250 Restricted Stock Units to six new non-executive employees.

Heron Therapeutics, Inc. presented at the Society for Obstetric Anesthesia and Perinatology 54th Annual Meeting results from a Phase 2 open-label, multi-cohort study evaluating interim safety and efficacy of ZYRNELEF extended-release solution administered postpartum to women undergoing a planned Caesarean section.

INVO Bioscience, Inc. announced financial results for the first quarter ended March 31, 2022 and provided a business update.

BIOLASE, Inc., the global leader in dental lasers, announced that it has been invited to present at the Spring Into Action Best Ideas Virtual Investor Conference being held May 17-20, 2022.

TherapeuticsMD, Inc., an innovative, leading women’s healthcare company, reported financial results for the first quarter ended March 31, 2022.

Exicure, Inc. reported financial results for the quarter ended March 31, 2022 and provided an update on its business strategy and corporate progress.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced the evolution of its research organization.

Emmes announced that it is providing data, statistical analysis, and project management support for new research that will test the Moderna mRNA vaccine at more than 50 sites in South and East Africa.